Literature DB >> 11157604

BAL and serum IgG levels in healthy asymptomatic HIV-infected patients.

R J Fahy1, P T Diaz, J Hart, M D Wewers.   

Abstract

OBJECTIVES: To determine if the increased susceptibility to bacterial infection in asymptomatic HIV-infected patients is associated with decreased total IgG or IgG2 levels in lung epithelial lining fluid.
BACKGROUND: A decrease in lung IgG levels or subtypes has been proposed as contributing to the increased risk of bacterial lung infections in HIV-infected patients. Previous studies measuring lung lavage IgG concentrations have been inconsistent.
METHODS: Twenty-three HIV patients and 25 control subjects underwent BAL. Both patient groups were of similar age, and had similar pulmonary function studies and body mass index. Smokers were equally represented in both groups, and the majority of subjects in both groups were male. Total IgG and IgG2 levels in lavage fluid were assayed in both cohorts and compared using a two-tailed Student's t test.
RESULTS: The lung lining fluid IgG level in HIV-infected patients was 0.19 +/- 0.13 microg/microg of protein (mean +/- SD) vs 0.11 +/- 0.09 microg/microg of protein in control subjects (p < 0.05). The IgG(2) level in HIV patients was 0.034 +/- 0.038 microg/microg of protein and 0.014 +/- 0.01 microg/microg of protein in control subjects (p = 0.054). Lavage IgG levels reflected serum IgG values (correlation coefficient, 0.56; p < 0.001) but did not correlate with lung immunoglobulin-producing cells.
CONCLUSIONS: The increased susceptibility to bacterial pneumonia in asymptomatic HIV-infected individuals is neither explained by depressed total IgG levels nor a deficiency in IgG(2) levels in the lungs. The strong correlation between serum and lavage IgG levels suggests that lavage IgG derives from serum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157604     DOI: 10.1378/chest.119.1.196

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

Review 1.  The immunocompromised host: HIV infection.

Authors:  James M Beck
Journal:  Proc Am Thorac Soc       Date:  2005

2.  Alveolar and serum antiphospholipid antibodies in acute respiratory distress syndrome associated with catastrophic antiphospholipid syndrome.

Authors:  F J Wiedermann
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

3.  Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1.

Authors:  Teena Mohan; D Mitra; D N Rao
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

Review 4.  Lung microbiome in human immunodeficiency virus infection.

Authors:  Homer L Twigg; George M Weinstock; Kenneth S Knox
Journal:  Transl Res       Date:  2016-07-18       Impact factor: 7.012

5.  An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques.

Authors:  Yongjun Sui; Jianping Li; Hanne Andersen; Roushu Zhang; Sunaina K Prabhu; Tanya Hoang; David Venzon; Anthony Cook; Renita Brown; Elyse Teow; Jason Velasco; Laurent Pessaint; Ian N Moore; Laurel Lagenaur; Jim Talton; Matthew W Breed; Josh Kramer; Kevin W Bock; Mahnaz Minai; Bianca M Nagata; Hyoyoung Choo-Wosoba; Mark G Lewis; Lai-Xi Wang; Jay A Berzofsky
Journal:  PNAS Nexus       Date:  2022-06-17

Review 6.  Impact of antiretroviral therapy on lung immunology and inflammation.

Authors:  Homer L Twigg; Kenneth S Knox
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

7.  HIV-Related Lung Disorders.

Authors:  Homer L Twigg; Kenneth S Knox
Journal:  Drug Discov Today Dis Mech       Date:  2007

8.  B cell, CD8 + T cell and gamma delta T cell infiltration alters alveolar immune cell homeostasis in HIV-infected Malawian adults.

Authors:  Andrew Mwale; Annemarie Hummel; Leonard Mvaya; Raphael Kamng'ona; Elizabeth Chimbayo; Joseph Phiri; Rose Malamba; Anstead Kankwatira; Henry C Mwandumba; Kondwani C Jambo
Journal:  Wellcome Open Res       Date:  2018-04-06

9.  Simultaneous Administration of Recombinant Measles Viruses Expressing Respiratory Syncytial Virus Fusion (F) and Nucleo (N) Proteins Induced Humoral and Cellular Immune Responses in Cotton Rats.

Authors:  Yoshiaki Yamaji; Akihito Sawada; Yosuke Yasui; Takashi Ito; Tetsuo Nakayama
Journal:  Vaccines (Basel)       Date:  2019-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.